Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes. | Front Immunol | 2022 | 35844607 | PubTator, text mining | PubMed |
| Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope. | Front Immunol | 2022 | 35844587 | PubTator, text mining | PubMed |
| Emerging Roles of T Helper Cells in Non-Infectious Neuroinflammation: Savior or Sinner. | Front Immunol | 2022 | 35844577 | PubTator, text mining | PubMed |
| Two Main Cellular Components in Rheumatoid Arthritis: Communication Between T Cells and Fibroblast-Like Synoviocytes in the Joint Synovium. | Front Immunol | 2022 | 35844494 | PubTator, text mining | PubMed |
| Human monocytes differentiate into tumor-associated macrophages upon SKOV3 cells coculture and/or lysophosphatidic acid stimulation. | J Inflamm (Lond) | 2022 | 35842650 | PubTator, text mining | PubMed |
| Research progress on serological indices and their clinical application in rheumatoid arthritis. | J Clin Lab Anal | 2022 | 35838016 | PubTator, text mining | PubMed |
| Increased cytokine gene expression and cognition risk associated with androgen deprivation therapy. | Prostate | 2022 | 35821621 | PubTator, text mining | PubMed |
| The Inflammatory Factor SNP May Serve as a Promising Biomarker for Acitretin to Alleviate Secondary Failure of Response to TNF-a Monoclonal Antibodies in Psoriasis. | Front Pharmacol | 2022 | 35814239 | PubTator, text mining | PubMed |
| Transcriptome sequencing analysis revealed the molecular mechanism of podoplanin neutralization inhibiting ischemia/reperfusion-induced microglial activation. | Ann Transl Med | 2022 | 35813319 | PubTator, text mining | PubMed |
| Investigation of the Molecular Mechanisms Underlying the Antiatherogenic Actions of Kaempferol in Human THP-1 Macrophages. | Int J Mol Sci | 2022 | 35806463 | PubTator, text mining | PubMed |
| Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis. | Dermatol Ther (Heidelb) | 2022 | 35798920 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? | Cell Death Dis | 2022 | 35787632 | PubTator, text mining | PubMed |
| Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics. | Ital J Dermatol Venerol | 2022 | 35785927 | PubTator, text mining | PubMed |
| Long Intergenic Noncoding RNA MIAT as a Regulator of Human Th17 Cell Differentiation. | Front Immunol | 2022 | 35784351 | PubTator, text mining | PubMed |
| Vaccination Recommendations for Psoriasis and Atopic Dermatitis Patients on Biologic Therapy: A Practical Guide. | Yale J Biol Med | 2022 | 35782480 | PubTator, text mining | PubMed |
| Physical Activity Associates With Lower Systemic Inflammatory Gene Expression in Rheumatoid Arthritis. | J Rheumatol | 2022 | 35777820 | PubTator, text mining | PubMed |
| Function-specific IL-17A and dexamethasone interactions in primary human airway epithelial cells. | Sci Rep | 2022 | 35773318 | PubTator, text mining | PubMed |
| circRNA: Regulatory factors and potential therapeutic targets in inflammatory dermatoses. | J Cell Mol Med | 2022 | 35770323 | PubTator, text mining | PubMed |
| Sex Differences in Airway Remodeling and Inflammation: Clinical and Biological Factors. | Front Allergy | 2022 | 35769576 | PubTator, text mining | PubMed |
| Differential Contribution of NF-κB Signaling Pathways to CD4+ Memory T Cell Induced Activation of Endothelial Cells. | Front Immunol | 2022 | 35769477 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=51